Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05976984 · ClinicalTrials.gov registry record
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 634,939
- Enrollment target
NCT05976984: Completed study, sponsored by University of Pennsylvania.
NCT05976984 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 634,939 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05976984 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 634,939 participants
- Enrollment target
Study Summary
This project addresses Objective 2 of RFA-CE-21-002: to assess risk and protective factors for illicit stimulant use, use disorder, or overdose that can contribute to the development or adaptation of intervention strategies. The study will 1) develop and validate a model using both person-level and area-level characteristics to identify, among Medicaid enrollees age 15 and older, who is at highest risk of an inpatient hospitalization or emergency department (ED) encounter for overdose from cocaine or other stimulants; 2) develop and validate a model to identify, among those Medicaid enrollees age 15 and older at highest risk of an inpatient hospitalization or ED encounter for stimulant overdose, when they are at highest risk; and 3) among those Medicaid enrollees age 15 and above with a prior inpatient hospitalization or ED encounter for stimulant overdose, to measure the rate of and identify risk and protective factors for a subsequent inpatient hospitalization or ED encounter for overdose from stimulants and/or opioids.
Primary Outcome
Rate of inpatient hospitalization or emergency department visit for overdose due to cocaine or other stimulants (Aims 1\&2)
Interventions
- OTHER Aim 1 (case-cohort study)
- OTHER Aim 2 (case-crossover study)
- OTHER Aim 3 (cohort study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634,939 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2025-08-18 |
What the finished NCT05976984 record still lists
NCT05976984 is an observational study that tracks outcomes without assigning an intervention. Its 634,939 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Aim 1 (case-cohort study) is the first listed.
NCT05976984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05976984 about?
NCT05976984 is a clinical study titled "Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk". This project addresses Objective 2 of RFA-CE-21-002: to assess risk and protective factors for illicit stimulant use, use disorder, or overdose that can contribute to the development or adaptation of intervention strategies. The study will 1) develop and validate a model using both person-level and ...
What is the current status of trial NCT05976984?
This trial is currently completed. The enrollment target is 634,939 participants. The study started on 2021-09-30. Estimated completion is 2025-08-18.
What interventions are being tested in trial NCT05976984?
The interventions under investigation include: Aim 1 (case-cohort study) (OTHER), Aim 2 (case-crossover study) (OTHER), Aim 3 (cohort study) (OTHER).
Who is sponsoring clinical trial NCT05976984?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI